Plain-English translation of NCT07249060 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Some people with cancer experience side effects when receiving immunotherapy (cancer treatments that boost the immune system to fight tumors). These side effects, called immune-related adverse events, happen when the immune system mistakenly attacks healthy tissues—similar to what happens in autoimmune diseases. This study is looking for blood markers that could predict who is most likely to develop these side effects before they happen.
Right now, doctors don't have a reliable test to identify which patients will experience these immune-related side effects from treatment. By comparing blood markers in cancer patients starting this medication with those in people who have autoimmune diseases, researchers hope to develop a simple blood test that can warn doctors which patients are at higher risk—allowing them to monitor more closely or take preventive steps.
You likely qualify if…
You likely don't qualify if…
You will be asked to provide small blood samples at scheduled times while you receive your cancer treatment as part of your regular medical care. Researchers will measure certain proteins in your blood to see if patterns can predict who develops side effects. The study involves no extra procedures beyond the blood draws—just samples taken during your normal clinic visits.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Spain